Tecentriq Hybreza is part of the
Monoclonal Antibodies class and treats
Lung Cancer,
Soft Tissue Sarcoma,
Liver Cancer and other conditions. Monoclonal antibodies are used to treat many conditions, including cancers, autoimmune diseases, and certain infections. They are similar to the antibodies in the body's immune system. But they are lab-made to have a specific target based on the condition they treat. Targets can include cancer cells, viruses, immune cells, and certain receptors in the body. Tecentriq Hybreza is only available as a brand name drug.
